Dambkowski Carl bought APGE
January 7, 2026 · Form 4 insider transaction
Dambkowski Carl bought 14,025 shares of Apogee Therapeutics, Inc. at $22.86 per share, a transaction worth $320.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
14,025
Price
$22.86
Total value
$320.6K
InsiderDambkowski Carl
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 7, 2026
Filing dateJanuary 9, 2026
Shares owned after231,223
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Due to an administrative error, the amount reported in Column 5 on the reporting person's Form 4 filed on October 3, 2025 was overstated by 53,910 shares. As a result, the beneficial ownership totals reported in the reporting person's Forms 4 filed after October 3, 2025 were each overstated by 53,910 shares. This Form 4 reflects the correct amount of common stock beneficially owned by the reporting person.